Literature DB >> 19430665

Toxoplasma gondii in animals used for human consumption.

Astrid M Tenter1.   

Abstract

Food-borne toxoplasmosis in humans may result from exposure to different stages of Toxoplasma gondii, in particular from the ingestion of tissue cysts or tachyzoites contained in meat, primary offal (viscera) or meat-derived products of many different animals, or the ingestion of sporulated oocysts that are contained in the environment and may contaminate food and water. Although the potential for transmission of the parasite to humans via food has been known for several decades, it is not known which routes are most important from a public health point of view. It is likely that transmission of the parasite to humans is influenced not only by the potential contamination of various food sources, but also by the individual behaviour of consumers in different ethnic groups and geographical regions. Most current methods for detection of T. gondii in meat-producing animals, in products of animal origin, or in the environment are insufficient because they do not allow quantification of infectious stages. Hence, most studies report only qualitative data from which it is difficult to assess the true risk of infection in individual cases. There is a need for quantitative data so that efficient strategies to reduce food-borne transmission of T. gondii to humans can be developed.

Entities:  

Mesh:

Year:  2009        PMID: 19430665     DOI: 10.1590/s0074-02762009000200033

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  49 in total

1.  Modulation of early β-defensin-2 production as a mechanism developed by type I Toxoplasma gondii to evade human intestinal immunity.

Authors:  Vijay Morampudi; Michel Y Braun; Sushila D'Souza
Journal:  Infect Immun       Date:  2011-03-07       Impact factor: 3.441

Review 2.  The impact of the waterborne transmission of Toxoplasma gondii and analysis efforts for water detection: an overview and update.

Authors:  Panagiotis Karanis; Hebatalla M Aldeyarbi; Marzieh E Mirhashemi; Khalil M Khalil
Journal:  Environ Sci Pollut Res Int       Date:  2012-09-19       Impact factor: 4.223

3.  Toxoplasmosis.

Authors:  Sandra K Halonen; Louis M Weiss
Journal:  Handb Clin Neurol       Date:  2013

Review 4.  Toxoplasma gondii infection among sheep and goats in Iran: a systematic review and meta-analysis.

Authors:  M Sharif; Sh Sarvi; A Shokri; S Hosseini Teshnizi; M T Rahimi; A Mizani; E Ahmadpour; A Daryani
Journal:  Parasitol Res       Date:  2014-11-08       Impact factor: 2.289

5.  Molecular survey of Toxoplasma infection in sheep and goat from Fars province, Southern Iran.

Authors:  Qasem Asgari; Jamshid Sarnevesht; Mohsen Kalantari; Seyed Jafar Adnani Sadat; Mohammad Hossein Motazedian; Bahador Sarkari
Journal:  Trop Anim Health Prod       Date:  2010-10-09       Impact factor: 1.559

6.  Sero-epidemiological investigation of bovine toxoplasmosis in traditional and smallholder cattle production systems of Tanga Region, Tanzania.

Authors:  Luuk B Schoonman; T Wilsmore; Emmanuel S Swai
Journal:  Trop Anim Health Prod       Date:  2009-09-29       Impact factor: 1.559

Review 7.  Toxoplasma gondii and the blood-brain barrier.

Authors:  Sabrina M Feustel; Markus Meissner; Oliver Liesenfeld
Journal:  Virulence       Date:  2012-03-01       Impact factor: 5.882

8.  Prevalence of toxoplasmosis in semi-domesticated and pet cats within and around Bangkok, Thailand.

Authors:  Tawin Inpankaew; Panpicha Sattasathuchana; Chanya Kengradomkij; Naris Thengchaisri
Journal:  BMC Vet Res       Date:  2021-07-22       Impact factor: 2.741

9.  Seroprevalence and risk factors for Toxoplasma gondii in sheep in Grosseto district, Tuscany, Italy.

Authors:  Beniamino T Cenci-Goga; Antonio Ciampelli; Paola Sechi; Fabrizia Veronesi; Iolanda Moretta; Valentina Cambiotti; Peter N Thompson
Journal:  BMC Vet Res       Date:  2013-02-07       Impact factor: 2.741

10.  Risk factors for acute toxoplasmosis in England and Wales.

Authors:  B Said; K D Halsby; C M O'Connor; J Francis; K Hewitt; N Q Verlander; E Guy; D Morgan
Journal:  Epidemiol Infect       Date:  2016-09-28       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.